The entity owns Beta (Systematic Risk) of 0.0 which indicates the returns on MARKET and SOCRUS BIO are completely uncorrelated. Although it is extremely important to respect SOCRUS BIO SCIENCES existing price patterns, it is better to be realistic regarding the information on equity price patterns. The approach towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By inspecting SOCRUS BIO SCIENCES technical indicators you can now evaluate if the expected return of 0.0% will be sustainable into the future. SOCRUS BIO SCIENCES currently owns a risk of 0.0%. Please validate SOCRUS BIO SCIENCES LIMITED Semi Deviation, Jensen Alpha as well as the relationship between Jensen Alpha and Semi Variance to decide if SOCRUS BIO SCIENCES LIMITED will be following its current price history.
|Horizon||30 Days Login to change|
SOCRUS BIO SCIENCES Relative Risk vs. Return LandscapeIf you would invest 48.00 in SOCRUS BIO SCIENCES LIMITED on December 21, 2018 and sell it today you would earn a total of 0.00 from holding SOCRUS BIO SCIENCES LIMITED or generate 0.0% return on investment over 30 days. SOCRUS BIO SCIENCES LIMITED is generating negative expected returns and assumes 0.0% volatility on return distribution over the 30 days horizon. Simply put, 0% of equities are less volatile than SOCRUS BIO and 99% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
Daily Expected Return (%)
SOCRUS BIO Market Risk Analysis
Sharpe Ratio = 0.0
Risk-Adjusted PerformanceOver the last 30 days SOCRUS BIO SCIENCES LIMITED has generated negative risk-adjusted returns adding no value to investors with long positions.